Core Viewpoint - The approval of LIM HUI HUNG LUANNE as the chairman of Hang Seng Bank (China) Limited by the Shanghai Regulatory Bureau of the National Financial Supervision Administration emphasizes the importance of compliance with financial regulations and the need for continuous learning in economic and financial laws [1] Group 1 - The Shanghai Regulatory Bureau has approved the appointment of LIM HUI HUNG LUANNE as the chairman of Hang Seng Bank (China) Limited [1] - Hang Seng Bank (China) is required to ensure that the approved personnel assume their positions within three months of the decision and report their status within ten days of taking office [1] - The bank must encourage the approved personnel to continuously learn and understand relevant economic and financial laws and regulations, and to maintain a strong awareness of risk compliance [1]

经初步测算，此次交易预计构成重大资产重组，不构成关联交易，不涉及发行股份，也不会导致控制权 变更。 近日，南华生物发布公告称，其于2025年8月12日披露拟现金收购程泽能等合计持有的慧泽医药51%股 权，交易完成后慧泽医药将成为其控股子公司。 不过，截至公告披露日，针对慧泽医药的审计、评估等工作仍在进行，相关方就核心条款谈判，尚未签 署正式收购协议，交易能否实施存在不确定性。 ...

Group 1 - The core viewpoint of the articles highlights the operational strategies and future outlook of the company, particularly in terms of capacity utilization and cost management [1][2] Group 2 - The company reported that since November of the previous year, it has gradually entered a peak season for stocking, with plans to complete capacity expansion based on anticipated order growth, but not exceeding one year in advance [1] - The joint venture with Feihe is aimed at developing domestically sourced, deep-processed raw materials, with a focus on utilizing by-products from Feihe's production processes, which are essential for the company's cream and baked dairy product business [1] - The company expects to see a significant reduction in sales and management expense ratios in the first three quarters of 2025 compared to the previous year, driven by scale effects from sales growth and improved logistics efficiency [2] - The company plans to reduce the number of external warehouses from over thirty to a dozen by mid-2025, which is expected to enhance inventory turnover efficiency and lower expense ratios [2] - The completion of centralized procurement at the headquarters by mid-2025 is anticipated to yield cost reduction effects that will be gradually realized [2]

关于对外投资进展情况，公告指出，近日，澳大利亚孙公司已完成公司注册及税务注册，并取得税务档 案编号。该公司名称为三全食品澳大利亚有限公司，由开曼全资孙公司持股100%，系公司全资孙公 司。 （企业公告） 1月7日，三全食品发布公告称，公司于2025年7月21日召开第九届董事会第二次会议审议通过了《关于 对外投资设立境外子公司及孙公司的议案》，同意公司在中国香港设立全资子公司、由中国香港子公司 在开曼群岛投资设立一家全资子公司，由开曼孙公司出资在澳大利亚设立孙公司，最终投资建设澳大利 亚生产基地并进行澳大利亚、新西兰及东南亚市场开拓。本次对外投资总额约为2.8亿澳元，资金来源 均为公司自有资金。公司已获得《企业境外投资证书》及《境外投资项目备案通知书》，全资子公司已 在中国香港完成注册登记。开曼全资孙公司已完成注册登记。 (编辑：王璨 林辰)关键字： 食品 三全食品 ...

Core Viewpoint - The controlling shareholders and executive directors of Maogeping Cosmetics Co., Ltd. plan to collectively reduce their holdings in the company, citing personal financial needs, despite the company's stock price having doubled since its IPO [1][11]. Shareholder Reduction Plan - The shareholders intend to reduce their holdings by up to 17.2 million H shares, representing no more than 3.51% of the company's total issued shares, primarily through block trades within six months from the announcement date [1]. - Based on the closing price of HKD 82 per share on January 6, the total cashing out amount is estimated at HKD 1.41 billion [1]. Shareholder Background - The shareholders involved in the reduction include Maogeping, his spouse Wang Liqun, and other family members, all of whom are executive directors of the company [1][4]. Financial Performance - For the first half of 2025, the company reported revenue of CNY 2.588 billion, a year-on-year increase of 31.3%, and a net profit of CNY 670 million, up 36.1% [10][11]. - The overall gross margin for the first half of 2025 was 84.2%, showing a slight decline compared to the same period in 2024 [11]. Market Reaction - Following the announcement of the share reduction, Maogeping's stock price rose by 7.26%, closing at HKD 87.95, with a market capitalization of HKD 43.112 billion [4][5]. Company Overview - Maogeping was founded in 2000 and went public in Hong Kong on December 10, 2024, recognized as the "first high-end domestic beauty stock" in the Hong Kong market [7]. - The company operates in cosmetics, makeup artistry training, product design, and development, with a significant online and e-commerce presence [10].

因以上事件影响，帝斯曼-芬美意ARA原料需求激增，我们将全力协调产能，满足市场需求。 作为全球ARA(花生四烯酸)营养原料的长期可靠供应商，帝斯曼-芬美意始终将产品质量与安全置于首 位。我们所生产的life'SARA 完全按照全球最高婴配级标准生产，确保每一步都可控、可溯、可靠。 今日，帝斯曼-芬美意官方公众号发布声明，表示公司关注到市场上关于某品牌婴儿奶粉因ARA原料安 全问题召回的事件，并有部分不实信息关联至帝斯曼-芬美意。我们对此高度重视，并郑重声明：涉事 问题ARA原料并非由帝斯曼-芬美意供应。 ...

1月6日，中邮理财发布公告称，根据中邮理财邮银财富·鸿元一年定开30号（核心优选）人民币理财产品（产品代码：2101AB0030）产品说明书中关于产品 终止条款的约定，因产品连续10个交易日总份额低于1亿份，为保护客户利益，该产品计划提前终止。该产品原定到期日为2032年1月15日，将于2026年1月 16日提前终止。 ...

Core Viewpoint - The company has issued a statement regarding the safety and supply chain of ARA (Arachidonic Acid) in response to a preventive recall in the European market due to potential contamination by Cereulid toxin [1] Group 1: Supplier Verification - The company confirmed that all products containing ARA are sourced from suppliers that are not involved in the European recall incident [1] - The ARA suppliers have undergone rigorous safety certification processes [1] Group 2: Testing Standards - The company emphasizes strict testing standards for microbial risks, particularly focusing on Bacillus cereus and its toxins [1] - Each batch of finished products has passed multiple sensory, physical, chemical, and microbiological tests conducted by third-party authoritative testing agencies, including tests for pathogenic bacteria [1]

1月6日，海峡金桥财产保险股份有限公司发布公告称，根据《福建金融监管局关于叶远航海峡金桥财险公司董事、董事长任职资格的批复》（闽金复 〔2025〕304号），自2025年12月25日起，施培德不再担任公司董事长，叶远航担任公司董事长。 同日，另一则公告显示，经该公司董事会决议，自2025年12月25日起，施培德担任公司临时负责人，代行总裁职责。 关于指定临时负责人的信息披露公' 经本公司董事会决议,自2025年12月25日起 德先生担任本公司临时负责人,代行总裁职责。 特此公告。 海峡金桥财产保险股份有 2026年1月6日 海峡金桥财产保险股份有限公司 临时信息披露报告(2026)2号 ...

以上投资者认购公司股份的认购金额均计入公司注册资本，增资后注册资本变更为25亿元。本次增资后，公司已发行的全部股份均转换为无面额股。 公司股东厦门象屿（600057）集团有限公司拟将其所持有的全部公司股权（合计22500万股股份）以及由该股权而派生的所有权益，转让给公司股东福建省 投资开发集团有限责任公司。每股转让价格为0.31元，转让股权总价为6975万元。 | )স্ | 股东名称 | 出资额 | 变更注册资本及股东前 | | | | --- | --- | --- | --- | --- | --- | | 흥 | | | 认购股份 | 持股 | 出资额 | | | | (万元) | (万股) | 比例 | (万元) | | 1 | 福建省投资开发 集团有限责任公 | 30000 | 30000 | 20% | 55000 | | | ות | | | | | | 2 | 福建发展高速公 | 27000 | 27000 | 18% | 18000 | | | 路股份有限公司 | | | | | | 3 | 福州市投资管理 | 25500 | 25500 | 17% | 17000 | | | 有限公司 ...